Aureus Pharma Changes Name; Launches Drug Discovery Web Portal | GenomeWeb

This week, Aureus Pharma said that it would continue its operations as Aureus Sciences, a name that it claims more accurately reflects its activities, and simultaneously launched a new web portal that grants entry to the company's cache of drug discovery tools and information.

In a statement, Jason Theodosiou, president and CEO of Aureus Sciences, said that the portal represents the first time that the company has offered "single-point access to all of our tools, applications, notes, scientific communications and technical documentation."

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

CBC Marketplace commissions DNA testing of chicken sandwiches at Subway and other fast-food chains.

In a speech to Congress, President Donald Trump called the drug approval process at FDA "slow and burdensome."

In Genome Research this week: algorithm to tease out strains from metagenomic sequences, drug resistance mechanisms in cancer cells, and more.

Variants in the IFITM3 gene affect inflammatory response to infection, UPI reports.